Percutaneous coronary intervention Archives

COMPLETE revascularisation improves angina-related QoL

Presented By

Prof. Shamir Mehta, McMaster University, Canada

Trial

COMPLETE

Conference

ACC 2022

15 June, 2022 14:24

Plot twist for negative FAME 3 results: early QoL benefits of PCI

Presented By

Dr Frederik Zimmermann, Catharina Hospital, the Netherlands

Trial

FAME 3

Conference

ACC 2022

15 June, 2022 14:19

No FLAVOUR difference between FFR and IVUS for PCI guidance

Presented By

Prof. Bon-Kwon Koo, Seoul National University College of Medicine, Korea

Trial

FLAVOUR

Conference

ACC 2022

15 June, 2022 13:49

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By

Dr Birgit Vogel, Icahn School of Medicine, USA

Trial

TWILIGHT

Conference

ACC 2021

9 July, 2021 23:24

TALOS-AMI: Exploring outcomes after switching to clopidogrel versus ticagrelor at 1 month from MI

Presented By

Prof. Kiyuk Chang, Seoul St. Mary’s Hospital, South Korea

Trial

TALOS-AMI

Conference

ACC 2021

9 July, 2021 20:46

Clopidogrel monotherapy associated with better net outcomes relative to aspirin monotherapy 6-18 months after PCI

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-EXAM

Conference

ACC 2021

9 July, 2021 19:52

Better outcomes with invasive strategy if anatomic complete revascularisation is possible

Presented By

Dr Gregg Stone, Mount Sinai Medical Centre, USA

Trial

ISCHEMIA

Conference

ACC 2021

9 July, 2021 10:20

Trimetazidine after successful PCI not associated with fewer cardiac events

Presented By

Prof. Roberto Ferrari, University of Ferrara, Italy

Trial

ATPCI trial

Conference

ESC 2020

5 November, 2020 13:30

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

Presented By

Prof. Y.S. Jang, Yonsei University, South Korea

Trial

TICO

Conference

ACC 2020

8 September, 2020 15:29

TWILIGHT sub-study: same outcomes for diabetes patients

Presented By

Prof. D. Angiolillo, University of Florida - Jacksonville, USA

Trial

TWILIGHT, TWILIGHT-DM

Conference

ACC 2020

8 September, 2020 15:24

TWILIGHT sub-study: complex PCI patients

Presented By

Prof. G. Dangas, Icahn School of Medicine at Mount Sinai, USA

Trial

TWILIGHT

Conference

ACC 2020

8 September, 2020 15:20

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By

Prof. Renato D. Lopes, Duke University School of Medicine, USA

Trial

AUGUSTUS

Conference

ISTH 2020

8 September, 2020 14:59

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

Presented By

Prof. J. Alexander, Duke University, USA

Trial

AUGUSTUS

Conference

ACC 2020

8 September, 2020 14:06

PCI and CABG are equal in left main CAD

Presented By

Dr D.W. Park, Asan Medical School, South Korea

Trial

PRECOMBAT

Conference

ACC 2020

8 September, 2020 12:45

TAILOR-PCI misses endpoint but still provides valuable insights

Presented By

Prof. N. Pereira, Mayo Clinic, USA

Trial

TAILOR-PCI

Conference

ACC 2020

7 September, 2020 23:16

Drop aspirin after 3 months in non-STEMI ACS patients on dual antiplatelet therapy

Presented By

Prof. Usman Baber, Icahn School of Medicine at Mount Sinai, USA

Trial

TWILIGHT

Conference

AHA 2019

26 February, 2020 20:58

Colchicine: no difference in peri-procedural cardiovascular events 30 days post-PCI

Presented By

Dr Binita Shah, NYU School of Medicine, USA

Trial

COLCHINE-PCI

Conference

AHA 2019

26 February, 2020 17:04

Intra-aortic balloon pump better than Impella: new observational data

Presented By

Dr Sanket S. Dhruva, University of California, San Francisco, USA

Conference

AHA 2019

26 February, 2020 15:06

Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin

Trial

AUGUSTUS

Conference

ACC 2019

4 June, 2019 13:19

Medical Conferences

Tag: Percutaneous coronary intervention

COMPLETE revascularisation improves angina-related QoL

Plot twist for negative FAME 3 results: early QoL benefits of PCI

No FLAVOUR difference between FFR and IVUS for PCI guidance

Men and women benefit equally from early aspirin withdrawal following PCI

TALOS-AMI: Exploring outcomes after switching to clopidogrel versus ticagrelor at 1 month from MI

Clopidogrel monotherapy associated with better net outcomes relative to aspirin monotherapy 6-18 months after PCI

Better outcomes with invasive strategy if anatomic complete revascularisation is possible

Trimetazidine after successful PCI not associated with fewer cardiac events

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

TWILIGHT sub-study: same outcomes for diabetes patients

TWILIGHT sub-study: complex PCI patients

Finding the sweet spot of anticoagulation in AF patients with ACS

Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

PCI and CABG are equal in left main CAD

TAILOR-PCI misses endpoint but still provides valuable insights

Drop aspirin after 3 months in non-STEMI ACS patients on dual antiplatelet therapy

Colchicine: no difference in peri-procedural cardiovascular events 30 days post-PCI

Intra-aortic balloon pump better than Impella: new observational data

Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin